Skip to main content
HR 4439 116th Congress House Health Child health Drug safety, medical device, and laboratory regulation Health programs administration and funding Health promotion and preventive care Infectious and parasitic diseases

Creating Hope Reauthorization Act

Introduced: August 18, 2020 See on congress.gov
This bill died when the 116th Congress ended
It never became law before the 116th Congress (2019–2020) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 15 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 30, 2020
Received in the Senate.
Sep 29, 2020
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
Sep 29, 2020
DEBATE - The House proceeded with forty minutes of debate on H.R. 4439.
Sep 29, 2020
Considered under suspension of the rules. (consideration: CR H5023-5025)
Sep 29, 2020
Mr. Pallone moved to suspend the rules and pass the bill, as amended.
Sep 29, 2020
Placed on the Union Calendar, Calendar No. 451.
Sep 29, 2020
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-551.
Sep 29, 2020
The title of the measure was amended. Agreed to without objection.
Sep 29, 2020
Motion to reconsider laid on the table Agreed to without objection.
Sep 29, 2020
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H5023)
Sep 9, 2020
Ordered to be Reported (Amended) by Voice Vote.
Sep 9, 2020
Committee Consideration and Mark-up Session Held.
Sep 23, 2019
Referred to the Subcommittee on Health.
Sep 20, 2019
Introduced in House
Sep 20, 2019
Referred to the House Committee on Energy and Commerce.
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Creating Hope Reauthorization Act

This bill reauthorizes a Food and Drug Administration (FDA) program that awards priority review vouchers to manufacturers of drugs that treat rare pediatric diseases. (A priority review voucher entitles the voucher holder to priority review of a single human drug application.)

Specifically, the bill reauthorizes the program through FY2024, but the FDA may award a voucher afterwards in certain instances.

What's happening now September 30, 2020

Received in the Senate.

 Related & companion bills 1
 Bill text 4 versions

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4439: Creating Hope Reauthorization Act. 116th Congress. Open America. https://openamerica.io/bill/116-HR-4439/
MLA
"H.R. 4439: Creating Hope Reauthorization Act." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-HR-4439/.
Bluebook (legal)
H.R. 4439, 116th Cong. (2026), https://openamerica.io/bill/116-HR-4439/.
Markdown link
[H.R. 4439: Creating Hope Reauthorization Act](https://openamerica.io/bill/116-HR-4439/)
Report a problem